HighVista Strategies LLC
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
154 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 67.4% | $242,385,867 |
| Technology | 9.1% | $32,616,951 |
| Unclassified | 8.5% | $30,607,040 |
| Industrials | 5.5% | $19,810,669 |
| Consumer Cyclical | 2.9% | $10,478,055 |
| Financial Services | 2.3% | $8,419,688 |
| Utilities | 1.7% | $6,148,792 |
| Basic Materials | 0.9% | $3,064,480 |
| Communication Services | 0.6% | $2,210,915 |
| Consumer Defensive | 0.4% | $1,383,251 |
| Real Estate | 0.3% | $1,184,735 |
| Energy | 0.3% | $1,163,975 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PALI | Palisade Bio, Inc. | +719,295 | 2,019,326 | $3,533,820 | |
| DYN | Dyne Therapeutics, Inc. | +123,286 | 182,929 | $3,316,502 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | +113,273 | 352,085 | $4,893,981 | |
| OCUL | Ocular Therapeutix, Inc | +97,506 | 441,573 | $3,740,123 | |
| TYRA | Tyra Biosciences, Inc. | +96,218 | 131,304 | $5,028,943 | |
| CTMX | CytomX Therapeutics, Inc. | +94,116 | 288,057 | $1,353,867 | |
| ALKS | Alkermes plc. | +46,788 | 73,189 | $2,587,963 | |
| ABVX | Abivax S.A. | +41,069 | 113,254 | $12,610,832 | |
| CORZ | Core Scientific, Inc./tx | +39,900 | 103,412 | $1,547,043 | |
| CLDX | Celldex Therapeutics, Inc. | +37,592 | 89,397 | $2,835,672 | |
| U | Unity Software Inc. | +34,100 | 62,763 | $1,377,020 | |
| LBRX | Lb Pharmaceuticals Inc | +33,488 | 173,595 | $4,280,852 | |
| SLNO | Soleno Therapeutics Inc | +30,158 | 165,227 | $5,531,799 | |
| IMCR | Immunocore Holdings plc | +25,699 | 58,697 | $1,769,714 | |
| CPNG | Coupang, Inc. | +21,244 | 46,036 | $869,159 | |
| BBD | Bank Bradesco | +18,000 | 208,264 | $760,163 | |
| HPE | Hewlett Packard Enterprise Co | +13,800 | 89,981 | $2,142,447 | |
| NOK | Nokia Corp | +11,300 | 70,824 | $569,424 | |
| PCVX | Vaxcyte, Inc. | +10,598 | 124,647 | $7,243,237 | |
| KBR | Kbr, Inc. | +9,400 | 39,406 | $1,452,505 | |
| AXSM | Axsome Therapeutics, Inc. | +9,306 | 20,437 | $3,454,261 | |
| NVDA | Nvidia Corp | +8,200 | 22,420 | $3,910,048 | |
| JANX | Janux Therapeutics, Inc. | +7,940 | 49,383 | $686,423 | |
| AMZN | Amazon Com Inc | +5,000 | 22,397 | $4,664,623 | |
| XEL | Xcel Energy Inc | +4,500 | 12,558 | $997,607 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.\DE | −238,243 | 134,229 | $2,625,519 | |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | −151,076 | 78,187 | $699,773 | |
| COGT | Cogent Biosciences, Inc. | −139,616 | 197,051 | $7,584,492 | |
| CMPS | COMPASS Pathways plc | −134,573 | 364,360 | $2,014,910 | |
| OLMA | Olema Pharmaceuticals, Inc. | −123,888 | 117,601 | $1,753,430 | |
| RLAY | Relay Therapeutics, Inc. | −123,198 | 421,881 | $4,197,715 | |
| EWTX | Edgewise Therapeutics, Inc. | −79,206 | 91,931 | $2,895,826 | |
| MLYS | Mineralys Therapeutics, Inc. | −77,766 | 46,778 | $1,267,216 | |
| MAZE | Maze Therapeutics, Inc. | −70,503 | 99,850 | $2,980,522 | |
| GPCR | Structure Therapeutics Inc. | −69,092 | 123,909 | $5,972,413 | |
| XOMA | XOMA Royalty Corp | −66,103 | 46,814 | $1,468,555 | |
| PHVS | Pharvaris N.V. | −64,504 | 97,866 | $2,764,714 | |
| TERN | Terns Pharmaceuticals, Inc. | −61,155 | 114,307 | $6,026,265 | |
| LQDA | Liquidia Corp | −56,259 | 99,744 | $3,764,338 | |
| CYTK | Cytokinetics Inc | −55,921 | 58,643 | $3,865,160 | |
| APGE | Apogee Therapeutics, Inc. | −53,468 | 35,761 | $3,010,003 | |
| STOK | Stoke Therapeutics, Inc. | −52,922 | 62,617 | $2,038,809 | |
| TRVI | Trevi Therapeutics, Inc. | −52,634 | 53,525 | $638,553 | |
| RVMD | Revolution Medicines, Inc. | −50,931 | 69,309 | $6,740,300 | |
| RXO | RXO, Inc. | −47,900 | 43,038 | $629,215 | |
| SYRE | Spyre Therapeutics, Inc. | −41,942 | 146,264 | $7,377,556 | |
| PTGX | Protagonist Therapeutics, Inc | −39,693 | 33,852 | $3,568,000 | |
| CNTA | Centessa Pharmaceuticals plc | −38,526 | 5,964 | $236,890 | |
| AVTX | Avalo Therapeutics, Inc. | −37,009 | 58,622 | $875,226 | |
| QXO | QXO, Inc. | −32,400 | 26,320 | $511,134 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ORKA | Oruka Therapeutics, Inc. | 78,911 | $3,870,584 | |
| MLTX | MoonLake Immunotherapeutics | 193,955 | $3,615,321 | |
| DFTX | Definium Therapeutics, Inc. | 185,856 | $3,512,678 | |
| NRIX | Nurix Therapeutics, Inc. | 226,546 | $3,511,463 | |
| IVA | Inventiva S.A. | 615,666 | $3,416,946 | |
| ERAS | Erasca, Inc. | 181,069 | $2,929,696 | |
| XENE | Xenon Pharmaceuticals Inc. | 49,050 | $2,852,257 | |
| VERA | Vera Therapeutics, Inc. | 69,241 | $2,785,565 | |
| ALMS | Alumis Inc. | 112,929 | $2,487,825 | |
| EYPT | EyePoint, Inc. | 183,037 | $2,359,346 | |
| TNGX | Tango Therapeutics, Inc. | 104,193 | $2,179,717 | |
| ASMB | Assembly Biosciences, Inc. | 74,735 | $2,073,896 | |
| JAZZ | Jazz Pharmaceuticals plc | 10,838 | $2,048,923 | |
| NATL | NCR Atleos Corp | 40,100 | $1,747,558 | |
| ON | On Semiconductor Corp | 28,000 | $1,733,760 | |
| KOD | Kodiak Sciences Inc. | 43,569 | $1,660,850 | |
| AVTR | Avantor, Inc. | 186,500 | $1,462,160 | |
| MIRM | Mirum Pharmaceuticals, Inc. | 15,563 | $1,437,709 | |
| SVRA | Savara Inc | 250,999 | $1,370,454 | |
| KNX | Knight-Swift Transportation Holdings Inc. | 22,900 | $1,318,582 | |
| MU | Micron Technology Inc | 3,800 | $1,283,792 | |
| BLTE | Belite Bio, Inc | 8,033 | $1,280,781 | |
| JHX | James Hardie Industries plc | 65,598 | $1,242,426 | |
| KRC | Kilroy Realty Corp | 41,997 | $1,184,735 | |
| STX | Seagate Technology Holdings plc | 2,900 | $1,136,104 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ACLX | Arcellx, Inc. | 75,002 | $4,890,130 | |
| AGIO | Agios Pharmaceuticals, Inc. | 147,662 | $4,019,359 | |
| APLS | Apellis Pharmaceuticals, Inc. | 150,776 | $3,787,493 | |
| SEPN | Septerna, Inc. | 78,682 | $2,193,654 | |
| APP | AppLovin Corp | 2,482 | $1,672,421 | |
| UNF | Unifirst Corp | 7,727 | $1,490,538 | |
| CMPX | Compass Therapeutics, Inc. | 245,532 | $1,318,506 | |
| TMO | Thermo Fisher Scientific Inc. | 2,269 | $1,314,772 | |
| OFIX | Orthofix Medical Inc. | 85,049 | $1,289,342 | |
| ACHC | Acadia Healthcare Company, Inc. | 81,630 | $1,158,329 | |
| SCHW | Schwab Charles Corp | 10,601 | $1,059,145 | |
| SNDK | Sandisk Corp | 4,378 | $1,039,249 | |
| AFRM | Affirm Holdings, Inc. | 13,086 | $973,990 | |
| VST | Vistra Corp. | 5,673 | $915,225 | |
| BVN | Buenaventura Mining Co Inc | 29,649 | $825,131 | |
| ALC | Alcon Inc | 10,440 | $822,776 | |
| FOUR | Shift4 Payments, Inc. | 12,982 | $817,476 | |
| GTLB | Gitlab Inc. | 19,305 | $724,516 | |
| RBLX | Roblox Corp | 8,431 | $683,163 | |
| CNX | CNX Resources Corp | 17,624 | $648,034 | |
| ALV | Autoliv Inc | 5,243 | $622,344 | |
| DBVT | DBV Technologies S.A. | 15,877 | $304,362 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| DBC |
Invesco DB Commodity Index Tracking Fund
|
Held | 1,057,238 | $30,607,040 | 8.51% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 113,254 | $12,610,832 | 3.51% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 26,323 | $8,481,007 | 2.36% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 197,051 | $7,584,492 | 2.11% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 146,264 | $7,377,556 | 2.05% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 124,647 | $7,243,237 | 2.01% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 69,309 | $6,740,300 | 1.88% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Reduced | 114,307 | $6,026,265 | 1.68% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Reduced | 123,909 | $5,972,413 | 1.66% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Reduced | 56,602 | $5,798,874 | 1.61% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Added | 225,139 | $5,592,452 | 1.56% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Added | 165,227 | $5,531,799 | 1.54% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Added | 131,304 | $5,028,943 | 1.40% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Added | 352,085 | $4,893,981 | 1.36% | |
| AMZN |
Amazon Com Inc
Consumer Cyclical
|
Added | 22,397 | $4,664,623 | 1.30% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
Added | 173,595 | $4,280,852 | 1.19% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Reduced | 421,881 | $4,197,715 | 1.17% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 24,316 | $3,976,152 | 1.11% | |
| NVDA |
Nvidia Corp
Technology
|
Added | 22,420 | $3,910,048 | 1.09% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 78,911 | $3,870,584 | 1.08% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 58,643 | $3,865,160 | 1.08% | |
| LQDA |
Liquidia Corp
Healthcare
|
Reduced | 99,744 | $3,764,338 | 1.05% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Added | 441,573 | $3,740,123 | 1.04% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Reduced | 52,464 | $3,680,349 | 1.02% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 49,560 | $3,680,325 | 1.02% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
NEW | 193,955 | $3,615,321 | 1.01% | |
| ARGX |
Argenx SE
Healthcare
|
Added | 4,918 | $3,591,369 | 1.00% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Reduced | 33,852 | $3,568,000 | 0.99% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
Added | 2,019,326 | $3,533,820 | 0.98% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
NEW | 185,856 | $3,512,678 | 0.98% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
NEW | 226,546 | $3,511,463 | 0.98% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Added | 20,437 | $3,454,261 | 0.96% | |
| IVA |
Inventiva S.A.
Healthcare
|
NEW | 615,666 | $3,416,946 | 0.95% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 182,929 | $3,316,502 | 0.92% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Reduced | 35,761 | $3,010,003 | 0.84% | |
| GHRS |
GH Research PLC
Healthcare
|
Reduced | 213,212 | $2,997,760 | 0.83% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 35,587 | $2,986,461 | 0.83% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Reduced | 99,850 | $2,980,522 | 0.83% | |
| ERAS |
Erasca, Inc.
Healthcare
|
NEW | 181,069 | $2,929,696 | 0.81% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 91,931 | $2,895,826 | 0.81% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Reduced | 73,102 | $2,865,598 | 0.80% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
NEW | 49,050 | $2,852,257 | 0.79% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Added | 89,397 | $2,835,672 | 0.79% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
NEW | 69,241 | $2,785,565 | 0.77% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Reduced | 97,866 | $2,764,714 | 0.77% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Reduced | 134,229 | $2,625,519 | 0.73% | |
| ALKS |
Alkermes plc.
Healthcare
|
Added | 73,189 | $2,587,963 | 0.72% | |
| ALMS |
Alumis Inc.
Healthcare
|
NEW | 112,929 | $2,487,825 | 0.69% | |
| MSFT |
Microsoft Corp
Technology
|
Reduced | 6,457 | $2,390,187 | 0.66% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
NEW | 183,037 | $2,359,346 | 0.66% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.